Pearl, a renowned dental technology company, has announced that its groundbreaking dental pathology detection aid, Second Opinion, has received clearance from the Turkish Medicines and Medical Devices Agency (TMMDA) as a Class IIa medical device. This regulatory approval in Turkey adds to the growing list of global clearances obtained by Second Opinion, which already includes countries such as the United States, United Kingdom, European Union, Canada, Australia, and more.
Second Opinion, Pearl’s flagship AI solution, is specifically designed to assist dental professionals in analyzing radiographs in patients aged 12 and above. By harnessing the power of computer vision and machine learning, the system automatically identifies and detects various dental conditions, both pathological and non-pathological. These include dental caries, bone loss, root abscesses, calculus, faulty restorations, impactions, crowns, fillings, root canals, implants, and more. The AI algorithm provides real-time findings, allowing dentists to display and discuss the results with patients during their visit.
Ophir Tanz, the founder and CEO of Pearl, expressed the company’s unwavering commitment to equipping dental practices worldwide with the most advanced AI technology available. Tanz emphasized that the authorization of Second Opinion for use in Turkey will bring unrivaled clinical benefits of AI to one of the fastest-growing dental markets in the world.
Dentists in Turkey can now take full advantage of Pearl’s Second Opinion by visiting the company’s website and requesting a demonstration. This cutting-edge AI solution promises to significantly improve the accuracy of x-ray evaluations and enhance doctor-patient communication in dental practices across Turkey.
Pearl, a leading dental technology company, has announced that its innovative dental pathology detection aid, Second Opinion, has been granted clearance by the Turkish Medicines and Medical Devices Agency (TMMDA) as a Class IIa medical device. This regulatory approval in Turkey further expands the global reach of Second Opinion, which has already received clearances in countries such as the United States, United Kingdom, European Union, Canada, Australia, and more.
Second Opinion, Pearl’s flagship AI solution, is specifically designed to assist dental professionals in analyzing radiographs in patients aged 12 and above. By utilizing computer vision and machine learning, the system automatically detects and identifies various dental conditions, both pathological and non-pathological. These include dental caries, bone loss, root abscesses, calculus, faulty restorations, impactions, crowns, fillings, root canals, implants, and more. The AI algorithm provides real-time findings, enabling dentists to present and discuss the results with patients during their visit.
Ophir Tanz, the founder and CEO of Pearl, highlighted the company’s dedication to equipping dental practices worldwide with the most advanced AI technology available. Tanz emphasized that the approval of Second Opinion for use in Turkey will bring unparalleled clinical benefits of AI to one of the fastest-growing dental markets in the world.
Dentists in Turkey can now access Pearl’s Second Opinion by visiting the company’s website and requesting a demo. This state-of-the-art AI solution promises to enhance the accuracy of x-ray evaluations and improve doctor-patient communication in dental practices throughout Turkey.